Clinical Psychopharmacology and Neuroscience indexed in CAS, DOI/Crossref, EMBASE, Korea Citation Index (KCI), KoreaMed, Korea Medical Citation Index (KoMCI), PubMed, PubMed Central (PMC), SCOPUS, SCI-expanded (SCIE), and Google Scholar:eISSN 2093-4327   pISSN 1738-1088

Download original image
Fig. 2. Effects of mood stabilizers, antipsychotics and antidepressants on neuroplasticity through cell signaling systems. 5-HT, serotonin; 5-HTR, serotonin receptor; AC, adenylyl cyclase; AR, adrenergic receptor; BDNF, brain-derived neurotrophic factor; cAMP, cyclic adenosine-3′,5′-monophosphate; CREB, cAMP-responsive element binding protein; ERK, extracellular signal-regulated kinase; Gs, G proteins; GSK-3β, glycogen synthase kinase-3β; MEK, Ras/Raf/Mitogen-activated protein kinase (MAP)/ERK kinase; NE, norepinephrine; NMDA, N-methyl-D-aspartate receptor; PI3K, phosphoinositide 3-kinase; PKA, protein kinase A; Shc, Src homology and containing protein; Sos, son of sevenless; TrkB, tropomyosin receptor kinase B. Original illustration created with BioRender.com by MK Seo.
2022;20:228~239 https://doi.org/10.9758/cpn.2022.20.2.228
© Clin Psychopharmacol Neurosci